This week, Johnson & Johnson paused a clinical trial of its COVID-19 vaccine candidate because one of its 60,000 participants is experiencing an “unexplained illness.” This comes after AstraZeneca briefly paused a trial just last month after one of its 30,000 subjects had experienced an illness. That trial resumed once an investigation revealed that the illness was unrelated to the test vaccine, but the delay is not harmless.

Although any slowdown in the testing of a vaccine is a disappointment for a world eager to return to normal as soon as possible, both of these pauses should help debunk the dangerous fearmongering being pushed by the media and leading Democrats that President Trump is somehow going to rush out an unsafe vaccine before the election.